DK1646391T3 - Anvendelse af 2H-[1,3]-oxazino[3,2-A]indolderivater til behandling af neuropatisk smerte - Google Patents

Anvendelse af 2H-[1,3]-oxazino[3,2-A]indolderivater til behandling af neuropatisk smerte

Info

Publication number
DK1646391T3
DK1646391T3 DK04740899T DK04740899T DK1646391T3 DK 1646391 T3 DK1646391 T3 DK 1646391T3 DK 04740899 T DK04740899 T DK 04740899T DK 04740899 T DK04740899 T DK 04740899T DK 1646391 T3 DK1646391 T3 DK 1646391T3
Authority
DK
Denmark
Prior art keywords
oxazino
treatment
neuropathic pain
indole derivatives
indole
Prior art date
Application number
DK04740899T
Other languages
Danish (da)
English (en)
Inventor
Lorenzo Polenzani
Angelo Guglielmotti
Alessandra Alisi
Nicola Cazzolla
Original Assignee
Acraf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acraf filed Critical Acraf
Application granted granted Critical
Publication of DK1646391T3 publication Critical patent/DK1646391T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5365—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Indole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK04740899T 2003-07-18 2004-07-08 Anvendelse af 2H-[1,3]-oxazino[3,2-A]indolderivater til behandling af neuropatisk smerte DK1646391T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT001467A ITMI20031467A1 (it) 2003-07-18 2003-07-18 Farmaco attivo nel dolore neuropatico
PCT/EP2004/007633 WO2005014001A1 (en) 2003-07-18 2004-07-08 Use of 2h- [1, 3] - oxazino [3, 2-a] indole derivatives for the treatment of neuropathic pain

Publications (1)

Publication Number Publication Date
DK1646391T3 true DK1646391T3 (da) 2007-03-19

Family

ID=34131193

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04740899T DK1646391T3 (da) 2003-07-18 2004-07-08 Anvendelse af 2H-[1,3]-oxazino[3,2-A]indolderivater til behandling af neuropatisk smerte

Country Status (21)

Country Link
US (1) US20060211691A1 (de)
EP (1) EP1646391B1 (de)
JP (1) JP2006528142A (de)
KR (1) KR20060033784A (de)
CN (1) CN100409850C (de)
AR (1) AR045993A1 (de)
AT (1) ATE345137T1 (de)
AU (1) AU2004262876B2 (de)
CA (1) CA2526852C (de)
DE (1) DE602004003252T2 (de)
DK (1) DK1646391T3 (de)
EA (1) EA008927B1 (de)
ES (1) ES2276317T3 (de)
GE (1) GEP20084307B (de)
HK (1) HK1087027A1 (de)
IL (1) IL172156A0 (de)
IT (1) ITMI20031467A1 (de)
PL (1) PL1646391T3 (de)
PT (1) PT1646391E (de)
UA (1) UA81050C2 (de)
WO (1) WO2005014001A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101563075B (zh) * 2006-12-26 2011-09-28 大鹏药品工业株式会社 糖尿病性神经病治疗剂
DE102007058504A1 (de) 2007-12-05 2009-07-09 Acino Ag Transdermales therapeutisches System mit einem Gehalt an einem Modulator für nikotinische Acetylcholinrezeptoren (nAChR)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5189041A (en) * 1990-11-16 1993-02-23 Syntex (U.S.A.) Inc. Tricyclic 5-ht3 receptor antagonists
GB9120628D0 (en) * 1991-09-27 1991-11-06 Fujisawa Pharmaceutical Co Pyrrolobenzoxazine derivatives and process for preparation thereof
DE69333504T2 (de) * 1992-03-12 2005-05-12 Smithkline Beecham P.L.C., Brentford N-(1-nButyl-4-piperidyl)methyl-3,4-dihydro-2H-1,3 oxazino 3,2-a indol-10-carboxamid oder ein pharmazeutisch annehmbares Salz davon
IL117438A (en) * 1995-03-16 2001-12-23 Lilly Co Eli Indazolecarboxamides, their preparation and pharmaceutical compositions containing them
US6326385B1 (en) * 1999-08-04 2001-12-04 Icagen, Inc. Methods for treating or preventing pain
US20040038874A1 (en) * 2002-08-22 2004-02-26 Osemwota Omoigui Method of treatment of persistent pain

Also Published As

Publication number Publication date
PT1646391E (pt) 2007-01-31
AU2004262876A1 (en) 2005-02-17
ITMI20031467A1 (it) 2005-01-19
US20060211691A1 (en) 2006-09-21
ATE345137T1 (de) 2006-12-15
GEP20084307B (en) 2008-02-11
KR20060033784A (ko) 2006-04-19
CA2526852A1 (en) 2005-02-17
EP1646391A1 (de) 2006-04-19
HK1087027A1 (en) 2006-10-06
EA008927B1 (ru) 2007-08-31
DE602004003252T2 (de) 2007-05-03
WO2005014001A1 (en) 2005-02-17
AR045993A1 (es) 2005-11-23
ES2276317T3 (es) 2007-06-16
AU2004262876B2 (en) 2010-05-20
IL172156A0 (en) 2006-04-10
CN100409850C (zh) 2008-08-13
DE602004003252D1 (de) 2006-12-28
JP2006528142A (ja) 2006-12-14
CA2526852C (en) 2011-08-30
EA200600270A1 (ru) 2006-06-30
WO2005014001A9 (en) 2005-05-26
CN1809361A (zh) 2006-07-26
EP1646391B1 (de) 2006-11-15
UA81050C2 (en) 2007-11-26
PL1646391T3 (pl) 2007-04-30

Similar Documents

Publication Publication Date Title
DK1803718T3 (da) 4-Tetrazolyl-4-phenylpiperidin-derivater til behandling af smerter
IS7941A (is) Bensasepínafleiður til að meðhöndla taugasjúkdóma
IS6616A (is) Setnar bísýklískar afleiður til meðhöndlunar á afbrigðilegum frumuvexti
DK1656346T3 (da) 1,2,3,4-tetrasubstituerede indol til behandling af luftvejssygdomme
DK1474416T3 (da) Dihydrobenzodiazepin-2-on-derivater til behandlingen af neurologiske lidelser
HK1091732A1 (en) Use of modified cyclosporins for the treatment of hcv disorders
AU2003249244A1 (en) Methods for the treatment of neoplasms
NL1025067A1 (nl) Pyrimidinederivaten voor de behandeling van abnormale celgroei.
EP1638508A4 (de) Shunt für die glaukombehandlung
IL174232A0 (en) Combinations of drugs for the treatment of neoplasms
ZA200500618B (en) Combinations of drugs for the treatment of neoplasms
DK1282616T3 (da) Hydroxyphenylpiperidin-4-ylidenmethylbenzamidderivater til behandling af smerter
DE602004021572D1 (de) SUBSTITUIERTE 8-PERFLUORO-6,7,8,9-TETRAHYDROPYRIMIDOi1,2-A PYRIMIDIN-4-ON-DERIVATE
PL374401A1 (en) 1-sulfonyl-4-aminoalkoxy indole derivatives as 5-ht6-receptor modulators for the treatment of cns-disorders
PL1685125T3 (pl) Pochodne pirrolowe użyteczne do leczenia chorób proliferacyjnych
AU2003251904A1 (en) Combinations of drugs for the treatment of neoplasms
DK1727801T3 (da) Til behandling af smerter anvendelige piperaziner
IL175137A0 (en) Bace455, an alternative splice variant of the human beta-secretase
NO20040497L (no) Amidinderivater for behandling av amyloidose
DK1646391T3 (da) Anvendelse af 2H-[1,3]-oxazino[3,2-A]indolderivater til behandling af neuropatisk smerte
AU2003274885A1 (en) Phenyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain or gastrointestinal disorders
AU2003202255A8 (en) Compositions for treatment of central nervous system neoplasms, and methods of making and using the same
SI1646391T1 (sl) Uporaba 2H-(1,3)-oksazino(3,2-A)indolnih derivatov za zdravljenje nevropatske bolecine
NO20042542L (no) Anvendelse av ascomycin for behandling av blefarit
DK1646387T3 (da) Anvendelse af indazol-derivater til behandling af neuropatiske smerter